Align Technology, Inc. (ALGN) is a Medical - Devices company in the Healthcare sector, currently trading at $184.69. It has a SharesGrow Score of 67/100, indicating a above average investment profile with 4 out of 7 criteria passed.
SharesGrow calculates the intrinsic value of ALGN = $338.84 (+83.5% from the current price, the stock appears undervalued). Analyst consensus target is ALGN = $197 (+6.8% upside).
Valuation: ALGN trades at a trailing Price-to-Earnings (P/E) of 30.4 (S&P 500 average ~25) with a forward Price/Earnings-to-Growth (PEG) of 3.44.
Financials: revenue is $4.0B, +2.6%/yr average growth. Net income is $410M, growing at +5.1%/yr. Net profit margin is 10.2% (healthy). Gross margin is 68.3% (-2.2 pp trend).
Balance sheet: total debt is $114M against $4.0B equity (Debt-to-Equity (D/E) ratio 0.03, conservative). Current ratio is 1.36 (adequate). Debt-to-assets is 1.8%. Total assets: $6.2B.
Analyst outlook: 24 / 33 analysts rate ALGN as buy (73%) — strong consensus.
SharesGrow 7-Criteria breakdown: Value 33/100 (Fail), Growth 55/100 (Partial), Past 100/100 (Pass), Health 83/100 (Pass), Moat 71/100 (Pass), Future 73/100 (Pass), Income 55/100 (Partial).
